LICENSE AND COLLABORATION AGREEMENTS (Tables)

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Certain Activity Related to Revenue with Supply Agreement

Contract manufacturing revenue and royalty revenue are included in collaboration and other revenues in the unaudited condensed consolidated statements of comprehensive (loss) income. The following table summarizes certain Roche activity for each of the periods indicated:

	For the Three Months Ended March 31,
	2025			2024
	(in thousands)
Contract manufacturing revenue	$	17,379		$	5,807
Royalty revenue		3,954			173
Cost of sales (inventory costs related to products sold to Roche)		(12,143	)		(1,654	)